BeiGene Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . BeiGene
ONC Stock   311.02  0.00  0.00%   
BeiGene's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BeiGene's valuation are provided below:
Gross Profit
4.3 B
Profit Margin
0.0138
Market Capitalization
34.4 B
Enterprise Value Revenue
6.5881
Revenue
5 B
We have found one hundred twenty available fundamental signals for BeiGene, which can be analyzed and compared to other ratios and to its rivals. Investors should ensure to validate all of BeiGene's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 2.2 B. The current year's Enterprise Value is expected to grow to about 935.1 M

BeiGene Total Revenue

4.6 Billion

Check BeiGene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BeiGene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 207.4 M, Interest Expense of 63.4 M or Selling General Administrative of 2.2 B, as well as many indicators such as Price To Sales Ratio of 0.67, Dividend Yield of 0.0 or PTB Ratio of 0.61. BeiGene financial statements analysis is a perfect complement when working with BeiGene Valuation or Volatility modules.
  
Build AI portfolio with BeiGene Stock
Check out the analysis of BeiGene Correlation against competitors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.

BeiGene Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.5 B6.8 B2.8 B
Slightly volatile
Short and Long Term Debt Total1.3 B1.2 B424.2 M
Slightly volatile
Other Current Liabilities1.1 B1 B337.5 M
Slightly volatile
Total Current Liabilities2.7 B2.5 B841.6 M
Slightly volatile
Property Plant And Equipment Net2 B1.9 B565.7 M
Slightly volatile
Current Deferred Revenue258.2 M245.9 M126.5 M
Slightly volatile
Accounts Payable489 M465.7 M164.8 M
Slightly volatile
Cash1.6 B3 B1.3 B
Slightly volatile
Non Current Assets Total2.3 B2.2 B692.3 M
Slightly volatile
Cash And Short Term Investments2.4 B3 B1.8 B
Slightly volatile
Common Stock Shares Outstanding70.3 M121.1 M57.3 M
Slightly volatile
Liabilities And Stockholders Equity3.5 B6.8 B2.8 B
Slightly volatile
Non Current Liabilities Total335.7 M429.9 M263.8 M
Slightly volatile
Other Current Assets112 M184.1 M89.4 M
Slightly volatile
Total Liabilities3.1 B3 B1.1 B
Slightly volatile
Total Current Assets2.8 B4.6 B2.2 B
Slightly volatile
Short Term Debt1 B999.5 M289 M
Slightly volatile
Common Stock88.9 K158.7 K73.2 K
Slightly volatile
Short Term Investments2.8 M3 M513.8 M
Pretty Stable
Net Receivables856.2 M815.5 M229 M
Slightly volatile
Good Will87.2 K98.1 K107.1 K
Slightly volatile
Inventory597.7 M569.2 M166.1 M
Slightly volatile
Intangible Assets78.1 M149.2 M54.9 M
Slightly volatile
Long Term Debt153.4 M149.8 M182.3 M
Slightly volatile
Capital Lease Obligations60 M71.1 M49.2 M
Slightly volatile
Net Invested Capital4 B3.9 B4.5 B
Very volatile
Long Term Investments101.3 M148.3 M70.8 M
Slightly volatile
Property Plant And Equipment Gross1.4 B2.4 B887.6 M
Slightly volatile
Short and Long Term Debt578.9 M979.3 M443.5 M
Slightly volatile
Capital Stock145 K158.7 K126 K
Slightly volatile
Non Current Liabilities Other60.3 M63.4 M290.7 M
Slightly volatile
Net Working Capital2.8 B1.6 B3.6 B
Slightly volatile
Other Assets655.9 M737.9 M805.4 M
Slightly volatile

BeiGene Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization207.4 M197.5 M50.2 M
Slightly volatile
Interest Expense63.4 M60.4 M27.9 M
Slightly volatile
Selling General Administrative2.2 B2.1 B672.3 M
Slightly volatile
Total Revenue4.6 B4.4 B1.1 B
Slightly volatile
Other Operating Expenses5.3 B5 B1.7 B
Slightly volatile
Research Development2.4 B2.2 B872.9 M
Slightly volatile
Cost Of Revenue717.4 M683.2 M246 M
Slightly volatile
Total Operating Expenses4.6 B4.4 B1.5 B
Slightly volatile
Tax Provision135 M128.6 M35.7 M
Slightly volatile
Interest Income48.5 M55 M20.7 M
Slightly volatile
Reconciled Depreciation207.4 M197.5 M66.3 M
Slightly volatile

BeiGene Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow3.8 B3.7 B1.3 B
Slightly volatile
Depreciation207.4 M197.5 M50.2 M
Slightly volatile
Capital Expenditures638.9 M608.5 M222 M
Slightly volatile
End Period Cash Flow1.6 B3 B1.3 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.670.747.3972
Pretty Stable
Days Sales Outstanding62.4261.1462.5437
Slightly volatile
Capex To Depreciation5.452.775.3186
Slightly volatile
Inventory Turnover1.311.3817.6987
Slightly volatile
Days Of Inventory On Hand166274129
Slightly volatile
Payables Turnover1.61.694.7496
Slightly volatile
Sales General And Administrative To Revenue0.330.480.458
Slightly volatile
Research And Ddevelopement To Revenue0.560.597.0842
Pretty Stable
Capex To Revenue0.150.161.5336
Very volatile
Cash Per Share21.6622.4621.8067
Slightly volatile
Days Payables Outstanding117224134
Slightly volatile
Intangibles To Total Assets0.02380.02520.0208
Pretty Stable
Current Ratio1.972.073.35
Pretty Stable
Receivables Turnover5.926.186.5804
Slightly volatile
Capex Per Share4.754.522.2881
Slightly volatile
Revenue Per Share34.232.5710.7138
Slightly volatile
Interest Debt Per Share9.699.235.4705
Slightly volatile
Debt To Assets0.350.210.6677
Slightly volatile
Operating Cycle228335192
Slightly volatile
Days Of Payables Outstanding117224134
Slightly volatile
Ebt Per Ebit1.121.081.1039
Slightly volatile
Quick Ratio1.721.823.2548
Pretty Stable
Net Income Per E B T0.821.091.0009
Slightly volatile
Cash Ratio1.361.071.3655
Slightly volatile
Days Of Inventory Outstanding166274129
Slightly volatile
Days Of Sales Outstanding62.4261.1462.5437
Slightly volatile
Fixed Asset Turnover1.32.071.622
Very volatile
Debt Ratio0.350.210.6677
Slightly volatile
Price Sales Ratio0.670.747.3972
Pretty Stable
Asset Turnover0.780.740.4519
Pretty Stable

BeiGene Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.2 B2.1 B1.2 B
Slightly volatile

BeiGene Fundamental Market Drivers

Forward Price Earnings38.1679
Cash And Short Term Investments2.6 B

About BeiGene Financial Statements

BeiGene stakeholders use historical fundamental indicators, such as BeiGene's revenue or net income, to determine how well the company is positioned to perform in the future. Although BeiGene investors may analyze each financial statement separately, they are all interrelated. For example, changes in BeiGene's assets and liabilities are reflected in the revenues and expenses on BeiGene's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BeiGene. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue245.9 M258.2 M
Total Revenue4.4 B4.6 B
Cost Of Revenue683.2 M717.4 M
Stock Based Compensation To Revenue 0.12  0.13 
Sales General And Administrative To Revenue 0.48  0.33 
Research And Ddevelopement To Revenue 0.59  0.56 
Capex To Revenue 0.16  0.15 
Revenue Per Share 32.57  34.20 
Ebit Per Revenue(0.13)(0.14)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
JBLJabil Circuit
MRKMerck Company
AMGNAmgen Inc
When determining whether BeiGene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BeiGene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Beigene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Beigene Stock:
How To Invest In BeiGene
Details
Is BeiGene Stock a good investment?
Details
What is BeiGene's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of BeiGene Correlation against competitors.
For information on how to trade BeiGene Stock refer to our How to Trade BeiGene Stock guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BeiGene. If investors know BeiGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BeiGene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.53
Revenue Per Share
45.987
Quarterly Revenue Growth
0.41
Return On Assets
0.0169
Return On Equity
0.0181
The market value of BeiGene is measured differently than its book value, which is the value of BeiGene that is recorded on the company's balance sheet. Investors also form their own opinion of BeiGene's value that differs from its market value or its book value, called intrinsic value, which is BeiGene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BeiGene's market value can be influenced by many factors that don't directly affect BeiGene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between BeiGene's value and its price as these two are different measures arrived at by different means. Investors typically determine if BeiGene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BeiGene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY